The First and Only FDA-Approved Blood Test for Colorectal Cancer Screening
For your patients who are unwilling or unable to be screened by other recommended methods (colonoscopy or stool tests), now there is a blood test – Epi proColon®.
1 in 3 are still unscreened for colorectal cancer.
As a result, 60% of colorectal cancer cases are diagnosed at later stages when cancer has spread.
What You Should Know About Epi proColon:
• A blood test is a convenient and patient-preferred method of testing
• Has no pretest requirements: bowel prep, stool handling, or dietary/medication restrictions
• Exhibits similar cancer detection rates to a fecal immunochemical test (FIT)
• Detects methylated Septin 9 DNA that is associated with colorectal cancer